Urinary fluorescence in situ hybridization assay for detecting urothelial carcinoma in Taiwanese patients

BJU International

Volumn 105, Issue 10, 2010, Pages 1413-1416

  Chuang, Kun Lung ^a   Chuang, Hun Chang ^a   Ng, Kwai Fong ^a   Chang, Ying Hsun ^a   Wu, Chun Te ^a   Chuang, Cheng Keng ^a   Liao, Shuen Kuei ^a   Pang, See Tong ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Bladder cancer; Cytogenetic; Fluorescence in situ hybridization; Urothelial carcinoma

Indexed keywords

SODIUM CHLORIDE;

ANALYTICAL EQUIPMENT; ARTICLE; ASIAN; BLADDER CANCER; CANCER DIAGNOSIS; CHROMOSOME 17; CHROMOSOME 3; CHROMOSOME 7; CHROMOSOME 9; CLINICAL ARTICLE; CYTOLOGY; EPITHELIUM CELL; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; POLYPLOIDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TAIWAN; URETER CATHETERIZATION; URINARY TRACT CARCINOMA;

ANEUPLOIDY; CARCINOMA, TRANSITIONAL CELL; GENETIC MARKERS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; POLYPLOIDY; SENSITIVITY AND SPECIFICITY; TAIWAN; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 77951719030     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08917.x     Document Type: Article

References (32)

1. Erckert M, Stenzl A, Falk M et al. Incidence of urethral tumor involvement in 910 men with bladder cancer. World J Urol 1996 14 : 3 8
2. Holmäng S, Hedelin H, Anderström C et al. Long-term followup of a bladder carcinoma cohort: routine followup urography is not necessary. J Urol 1998 160 : 45 8
3. Oosterlinck W. Guidelines on bladder cancer. Eur Urol 2002 41 : 105 112
4. Kurth K, Tunn U, Ay R et al. Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long-term Results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone. J Urol 1997 158 : 378 384
5. Sokolova IA, Halling KC, Jenkins RB et al. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. J Mol Diagn 2000 2 : 116 123
6. Liou LS. Urothelial cancer biomarkers for detection and surveillance. Urology 2006 67 (3 Suppl. 1 25 33
7. Messing E, Teot L, Korman H et al. Performance of urine test in patients monitored for recurrence of bladder cancer: a multicenter study in the united states. J Urol 2005 174 : 1238 1241
8. Stampfer DS, Carpinito GA, Rodriquez-Villanueva J. Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder. J Urol 1998 159 : 394 398
9. Huben RP, Mounzer AM, Murphy JP. Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer 2006 62 : 2016 2020
10. Miyake H, Hara I, Fujisawa M et al. Prognostic variables in patients with upper urinary tract cancers. Int J Clin Oncol 1996 1 : 135 138
11. Hall MC, Womack S, Sagalowsky AI. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 1998 52 : 594 601
12. Jones JS. DNA-based molecular cytology for bladder cancer surveillance. Urology 2006 67 (Suppl. 1 35 45
13. Skacel M, Fahmy M, Brainard JA et al. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol 2003 169 : 2101 2105
14. Sarosdy MF, Schellhammer P, Bokinsky G et al. Clinical evaluation of a multitarget fluorescent in situ hybridization assay for detection of bladder cancer. J Urol 2002 168 : 1950 1954
15. Halling K, King W, Sokolova I et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 2000 164 : 1768 1175
16. Ishiwata S, Takahashi S, Homma Y et al. Noninvasive detection and prediction of bladder cancer by fluorescence in situ hybridization analysis of exfoliated urothelial cells in voided urine. Urology 2001 57 : 811 815
17. Degtyar P, Neulander E, Zirkin H et al. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder. Urology 2004 63 : 398 401
18. Laudadio J, Keane TE, Reeves HM et al. Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practice. BJU Int 2005 96 : 1280 1285
19. Junker K, Fritsch T, Hartmann A et al. Multicolor fluorescence in situ hybridization (M-FISH) on cells from urine for the detection of bladder cancer. Cytogenet Genome Res 2006 114 : 279 283
20. Luo B, Li W, Deng C-H et al. Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma. Cancer Genet Cytogenet 2009 189 : 93 7
21. Marín-Aguilera M, Mengual L, Ribal MJ et al. Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma. Eur Urol 2007 51 : 409 415
22. Akkad T, Brunner A, Pallwein L et al. Fluorescence in situ hybridization for detecting upper urinary tract tumors - a preliminary report. Urology 2007 70 : 753 757
23. Chen AA, Grasso M. Is there a role for FISH in the management and surveillance of patients with upper tract transitional cell carcinoma? J Endourol 2008 22 : 1371 1374
24. Zellweger T, Benz G, Cathomas G et al. Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer. Int J Cancer 2006 119 : 1660 1665
25. Kunju L, Wojno K, Wolf J Jr. Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features. Hum Pathol 2008 39 : 96 101
26. Sartore-Bianchi A, Moroni M, Veronese S et al. Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab. J Clin Oncol 2007 25 : 3238 3245
27. Andersson S, Wallin K-L, Hellström AC et al. Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas. Br J Cancer 2006 95 : 331 338
28. Heselmeyer-Haddad K, Janz V, Castle PE et al. Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia. Am J Pathol 2003 163 : 1405 1416
29. Sandberg AA. Chromosome changes in early bladder neoplasms. J Cell Biochem Suppl 1992 161 : 76 9
30. Chang C-H, Yang C-M, Yang A-H. Renal diagnosis of chronic hemodialysis patients wih urinary tract transitional cell carcinoma in Taiwan. Cancer 2007 109 : 1487 1492
31. Chen KS, Lai MK, Huang CC, Chu SH, Leu ML. Urologic cancer in uremic patients. Am J Kidney Dis 1995 25 : 694 700
32. Ou JH, Pan CC, Lin JSN et al. Transitional cell carcinoma in dialysis patients. Eur Urol 2000 37 : 90 4